All lobbying filings
LMH Strategic Solutions
LMH Strategic Solutions filed a Q4 report for Savara Inc. on January 12, 2026, reporting $30,000 in lobbying income.
Lobbying for Savara Inc. · Biopharmaceutical company focused on rare respiratory diseases.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 12, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Pennsylvania
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Lobbying activity
2
Monitor prescription drug payment reform. Monitor supply chain.
Monitor Medicare/Medicaid issues.